{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:05:57Z","timestamp":1790269557006,"version":"4.1.0"},"reference-count":15,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"unspecified","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To develop and externally validate machine learning models for predicting disease flares in axial spondyloarthritis (axSpA) using real-world registry data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with axSpA receiving biological disease-modifying antirheumatic drugs in the METEOR-SpA registry were analysed at visit level. Flare was defined as an Axial Spondyloarthritis Disease Activity Score (ASDAS) increase \u22650.9 (or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) increase \u22652) at the next 6-month assessment. Candidate models utilising routine clinical predictors and minimum-redundancy maximum-relevance variable selection were optimised for average precision (AP) to account for class imbalance, evaluated using patient-grouped cross-validation (CV) and externally validated in the Groningen Leeuwarden AxSpA cohort (GLAS) using discrimination, calibration and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After eligibility criteria, 1167 patients and 3865 visits were included from the METEOR-SpA cohort; 618 (52.9%) patients had at least one visit with known flare status. Among them, 170 (27.5%) experienced at least one flare. A ridge logistic regression was selected as the final model with an internal CV receiver operating characteristic plot and area under the curve (ROC-AUC) of 0.72 (95% CI 0.70 to 0.75) and an AP of 0.291 (0.245 to 0.337), retaining eight predictors associated with flare. These were ASDAS (current and previous), female sex, flare history, enthesitis, infliximab exposure, physician global assessment and C reactive protein. In external validation in GLAS, ROC-AUC was 0.63 (95% CI 0.59 to 0.68) and AP 0.142 (0.116 to 0.171). DCA showed a modest positive net clinical benefit at low threshold probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A reduced logistic-regression model showed moderate internal and modest external discrimination for short-term flare risk in axSpA. While not intended to guide individual pre-emptive therapy modification, the model may support low-risk interventions such as group-level risk stratification or tighter follow-up after further validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2026-007147","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:35:15Z","timestamp":1790267715000},"page":"e007147","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting disease flares in axial spondyloarthritis using different machine learning models in the METEOR-SpA registry"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-5330","authenticated-orcid":false,"given":"Benavent","family":"D","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanjul","family":"V","sequence":"additional","affiliation":[{"name":"Savana Research, S.L, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-5248","authenticated-orcid":false,"given":"Bergstra","family":"S A","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8448-7407","authenticated-orcid":false,"given":"van Gaalen","family":"F","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-7640","authenticated-orcid":false,"given":"Arends","family":"S","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spoorenberg","family":"A","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Dougados","family":"M","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u0131l\u0131\u00e7","family":"L","sequence":"additional","affiliation":[{"name":"Hacettepe University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poddubnyy","family":"D","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Toronto, Canada and Department of Gastroenterology, Infectiology and Rheumatology, Charit\u00e9Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-5837","authenticated-orcid":false,"given":"L\u00f3pez-Medina","family":"C","sequence":"additional","affiliation":[{"name":"Reina Sofia University Hospital, IMIBIC, University of Cordoba, Cordoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parperis","family":"K","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Cyprus Medical School, Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-2202","authenticated-orcid":false,"given":"Vega-Morales","family":"D","sequence":"additional","affiliation":[{"name":"Reumatolog\u00eda y Centro de Infusi\u00f3n, Hospital General de Zona No. 17, Instituto Mexicano del Seguro Social, Monterrey, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-158X","authenticated-orcid":false,"given":"van der Heijde","family":"D","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-852X","authenticated-orcid":false,"given":"Navarro-Comp\u00e1n","family":"V","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026092409350952000_12.3.e007147.1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","article-title":"Axial spondyloarthritis","volume":"405","author":"Navarro-Comp\u00e1n","year":"2025","journal-title":"Lancet"},{"key":"2026092409350952000_12.3.e007147.2","doi-asserted-by":"crossref","DOI":"10.1093\/rap\/rkab082","article-title":"Understanding flare in axial spondyloarthritis: novel insights from daily self-reported flare experience","volume":"5","author":"Barnett","year":"2021","journal-title":"Rheumatol Adv Pract"},{"key":"2026092409350952000_12.3.e007147.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208593"},{"key":"2026092409350952000_12.3.e007147.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212178"},{"key":"2026092409350952000_12.3.e007147.5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003832","article-title":"Entry point of machine learning in axial spondyloarthritis","volume":"10","author":"Chen","year":"2024","journal-title":"RMD Open"},{"key":"2026092409350952000_12.3.e007147.6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10067-019-04803-y","article-title":"Machine learning\u2013based prediction of radiographic progression in patients with axial spondyloarthritis","volume":"39","author":"Joo","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026092409350952000_12.3.e007147.7","doi-asserted-by":"crossref","unstructured":"Xie Z , Lu Z , Chen H , et al . Prediction of treatment response according to ASAS-EULAR management recommendations in 1 year for hip involvement in axial spondyloarthritis based on MRI and clinical indicators. Front Endocrinol 2021;12. doi:10.3389\/fendo.2021.771997","DOI":"10.3389\/fendo.2021.771997"},{"key":"2026092409350952000_12.3.e007147.8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40744-021-00279-y","article-title":"Predictive value of active sacroiliitis in MRI for flare among Chinese patients with axial spondyloarthritis in remission","volume":"8","author":"Zheng","year":"2021","journal-title":"Rheumatol Ther"},{"key":"2026092409350952000_12.3.e007147.9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/rheumatology\/keae138","article-title":"Flare prediction after tapering the dose of tumour necrosis factor inhibitors in patients with axial spondyloarthritis: a nationwide cohort study","volume":"64","author":"Yeo","year":"2025","journal-title":"Rheumatology"},{"key":"2026092409350952000_12.3.e007147.10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/annrheumdis-2024-eular.5211","article-title":"Clinical features of patients with SpA, with or without IBD: results from the METEOR cohort","volume":"83","author":"Varkas","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026092409350952000_12.3.e007147.11","doi-asserted-by":"crossref","DOI":"10.1186\/ar3369","article-title":"Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study","volume":"13","author":"Arends","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2026092409350952000_12.3.e007147.12","doi-asserted-by":"crossref","unstructured":"Riley RD , Snell KIE , Ensor J , et al . Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Stat Med 2019;38. doi:10.1002\/sim.8409","DOI":"10.1002\/sim.8409"},{"key":"2026092409350952000_12.3.e007147.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100826"},{"key":"2026092409350952000_12.3.e007147.14","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2026092409350952000_12.3.e007147.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2026-007147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:35:20Z","timestamp":1790267720000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2026-007147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,24]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/rmdopen-2026-007147"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2026-007147","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}